Literature DB >> 24292435

In vitro stability of free and glucuronidated cannabinoids in urine following controlled smoked cannabis.

Nathalie A Desrosiers1, Dayong Lee, Karl B Scheidweiler, Marta Concheiro-Guisan, David A Gorelick, Marilyn A Huestis.   

Abstract

Analyte stability is an important factor in urine test interpretation, yet cannabinoid stability data are limited. A comprehensive study of Δ(9)-tetrahydrocannabinol (THC), 11-hydroxy-THC (11-OH-THC), 11-nor-9-carboxy-THC (THCCOOH), cannabidiol, cannabinol, THC-glucuronide, and THCCOOH-glucuronide stabilities in authentic urine was completed. Urine samples after ad libitum cannabis smoking were pooled to prepare low and high pools for each study participant; baseline concentrations were measured within 24 h at room temperature (RT), 4 °C and -20 °C. Stability at RT, 4 °C and -20 °C was evaluated by Friedman tests for up to 1 year. THCCOOH, THC-glucuronide, and THCCOOH-glucuronide were quantified in baseline pools. RT THCCOOH baseline concentrations were significantly higher than -20 °C, but not 4 °C baseline concentrations. After 1 week at RT, THCCOOH increased, THCCOOH-glucuronide decreased, but THC-glucuronide was unchanged. In RT low pool, total THCCOOH (THCCOOH + THCCOOH-glucuronide) was significantly lower after 1 week. At 4 °C, THCCOOH was stable 2 weeks, THCCOOH-glucuronide 1 month and THC-glucuronide for at least 6 months. THCCOOH was stable frozen for 1 year, but 6 months high pool results were significantly higher than baseline; THC-glucuronide and THCCOOH-glucuronide were stable for 6 months. Total THCCOOH was stable 6 months at 4 °C, and frozen 6 months (low) and 1 year (high). THC, cannabidiol and cannabinol were never detected in urine; although not detected initially, 11-OH-THC was detected in 2 low and 3 high pools after 1 week at RT. Substantial THCCOOH-glucuronide deconjugation was observed at RT and 4 °C. Analysis should be conducted within 3 months if non-hydrolyzed THCCOOH or THCCOOH-glucuronide quantification is required.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24292435      PMCID: PMC4259566          DOI: 10.1007/s00216-013-7524-7

Source DB:  PubMed          Journal:  Anal Bioanal Chem        ISSN: 1618-2642            Impact factor:   4.142


  24 in total

1.  Urine pH, container composition, and exposure time influence adsorptive loss of 11-nor-delta9-tetrahydrocannabinol-9-carboxylic acid.

Authors:  Matthew H Jamerson; Joseph J McCue; Kevin L Klette
Journal:  J Anal Toxicol       Date:  2005-10       Impact factor: 3.367

2.  Detection of Delta9-tetrahydrocannabinolic acid A in human urine and blood serum by LC-MS/MS.

Authors:  Julia Jung; Juergen Kempf; Hellmut Mahler; Wolfgang Weinmann
Journal:  J Mass Spectrom       Date:  2007-03       Impact factor: 1.982

3.  Investigation of the effects of solution composition and container material type on the loss of 11-nor-delta 9-THC-9-carboxylic acid.

Authors:  K D Roth; N A Siegel; R W Johnson; L Litauszki; L Salvati; C A Harrington; L K Wray
Journal:  J Anal Toxicol       Date:  1996-09       Impact factor: 3.367

4.  Reanalysis of forensic urine specimens containing benzoylecgonine and THC-COOH.

Authors:  R W Romberg; M R Past
Journal:  J Forensic Sci       Date:  1994-03       Impact factor: 1.832

5.  Stability of drugs of abuse in urine samples stored at -20 degrees C.

Authors:  S Dugan; S Bogema; R W Schwartz; N T Lappas
Journal:  J Anal Toxicol       Date:  1994 Nov-Dec       Impact factor: 3.367

Review 6.  Properties of acyl glucuronides: implications for studies of the pharmacokinetics and metabolism of acidic drugs.

Authors:  E M Faed
Journal:  Drug Metab Rev       Date:  1984       Impact factor: 4.518

7.  Microbiological oxidation of the pentyl side chain of cannabinoids.

Authors:  L W Robertson; S W Koh; S R Huff; R K Malhotra; A Ghosh
Journal:  Experientia       Date:  1978-08-15

8.  Simultaneous GC-EI-MS determination of Delta9-tetrahydrocannabinol, 11-hydroxy-Delta9-tetrahydrocannabinol, and 11-nor-9-carboxy-Delta9-tetrahydrocannabinol in human urine following tandem enzyme-alkaline hydrolysis.

Authors:  Tsadik T Abraham; Ross H Lowe; Stephane O Pirnay; William D Darwin; Marilyn A Huestis
Journal:  J Anal Toxicol       Date:  2007-10       Impact factor: 3.367

9.  Adsorption losses from urine-based cannabinoid calibrators during routine use.

Authors:  J A Blanc; V A Manneh; R Ernst; D E Berger; S A de Keczer; C Chase; J M Centofanti; A J DeLizza
Journal:  Clin Chem       Date:  1993-08       Impact factor: 8.327

10.  Stability of cannabinoids in urine in three storage temperatures.

Authors:  S Golding Fraga; J Díaz-Flores Estévez; C Díaz Romero
Journal:  Ann Clin Lab Sci       Date:  1998 May-Jun       Impact factor: 1.256

View more
  6 in total

1.  Recent Self-Reported Cannabis Use Is Associated With the Biometrics of Delta-9-Tetrahydrocannabinol.

Authors:  Matthew J Smith; Eva C Alden; Amy A Herrold; Andrea Roberts; Dan Stern; Joseph Jones; Allan Barnes; Kailyn P O'Connor; Marilyn A Huestis; Hans C Breiter
Journal:  J Stud Alcohol Drugs       Date:  2018-05       Impact factor: 2.582

2.  Automated analysis of dried urine spot (DUS) samples for toxicology screening.

Authors:  Abed Pablo; Autumn R Breaud; William Clarke
Journal:  Clin Biochem       Date:  2019-11-07       Impact factor: 3.281

3.  Urinary 11-nor-9-carboxy-tetrahydrocannabinol elimination in adolescent and young adult cannabis users during one month of sustained and biochemically-verified abstinence.

Authors:  Randi Melissa Schuster; Kevin Potter; Ryan Vandrey; Maya Hareli; Jodi Gilman; David Schoenfeld; A Eden Evins
Journal:  J Psychopharmacol       Date:  2019-09-19       Impact factor: 4.153

4.  Analysis of Cannabinoids and Their Metabolites in Human Urine.

Authors:  Binnian Wei; Lanqing Wang; Benjamin C Blount
Journal:  Anal Chem       Date:  2015-10-05       Impact factor: 6.986

5.  Simultaneous quantification of 11 cannabinoids and metabolites in human urine by liquid chromatography tandem mass spectrometry using WAX-S tips.

Authors:  Maria Andersson; Karl B Scheidweiler; Cristina Sempio; Allan J Barnes; Marilyn A Huestis
Journal:  Anal Bioanal Chem       Date:  2016-07-15       Impact factor: 4.142

6.  Toxicological screening in the Amsterdam acute setting becomes more relevant if the standard panel of the drugs-of-abuse point-of-care test is expanded with GHB and ketamine.

Authors:  J A J van der Schaar; M E Attema-de Jonge; F M J Gresnigt; E J F Franssen
Journal:  Toxicol Rep       Date:  2020-04-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.